Seishi Kono

1.3k total citations · 1 hit paper
15 papers, 940 citations indexed

About

Seishi Kono is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Seishi Kono has authored 15 papers receiving a total of 940 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 4 papers in Molecular Biology and 4 papers in Cancer Research. Recurrent topics in Seishi Kono's work include Cancer Cells and Metastasis (6 papers), Mesenchymal stem cell research (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Seishi Kono is often cited by papers focused on Cancer Cells and Metastasis (6 papers), Mesenchymal stem cell research (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Seishi Kono collaborates with scholars based in Japan. Seishi Kono's co-authors include Shintaro Takao, Hironobu Minami, Yohei Shimono, Toru Mukohara, Masanori Toyoda, Yoshinori Imamura, Naomi Kiyota, Yohei Funakoshi, Naoko Chayahara and Tetsuya Nakatsura and has published in prestigious journals such as Cancer Research, Oncogene and Breast Cancer Research and Treatment.

In The Last Decade

Seishi Kono

14 papers receiving 932 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Comparison of 2D- and 3D-culture models as drug-testing platforms in breast cancer

2015 639 citations Yoshinori Imamura, Toru Mukohara et al. Oncology Reports profile →

Peers

Countries citing papers authored by Seishi Kono

Since Specialization

Citations

This map shows the geographic impact of Seishi Kono's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seishi Kono with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seishi Kono more than expected).

Fields of papers citing papers by Seishi Kono

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Seishi Kono. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seishi Kono. The network helps show where Seishi Kono may publish in the future.

Co-authorship network of co-authors of Seishi Kono

This figure shows the co-authorship network connecting the top 25 collaborators of Seishi Kono. A scholar is included among the top collaborators of Seishi Kono based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Seishi Kono. Seishi Kono is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	High Frequency of BRCA2 c.5576_5579del Carriers in Kakogawa, Japan 2024 ·Cancer Diagnosis & Prognosis ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Kazuhiko Tsuchiya, Seishi Kono, (unknown), Sayaka Ueno, (unknown)	0
2	Adipsin-Dependent Secretion of Hepatocyte Growth Factor Regulates the Adipocyte-Cancer Stem Cell Interaction 2021 ·Cancers ·Masahiro Mizuno, (unknown), Masao Maeda, Takanori Hayashi, Seiya Mizuno, Eiji Munetsuna, Takashi Watanabe, Seishi Kono, Seiji Okada, Motoshi Suzuki, Shintaro Takao, Hironobu Minami, Naoya Asai, Fumihiro Sugiyama, Satoru Takahashi, Yohei Shimono	11
3	Upregulation of S100A10 in metastasized breast cancer stem cells 2020 ·Cancer Science ·(unknown), Takashi Watanabe, Tatsunori Nishimura, Takanori Hayashi, Seishi Kono, Hitomi Tsuchida, Munetsugu Hirata, Yuko Kijima, Shintaro Takao, Seiji Okada, Motoshi Suzuki, Kazuyoshi Imaizumi, Kenji Kawada, Hironobu Minami, Noriko Gotoh, Yohei Shimono	22
4	Physical activity among patients with breast cancer receiving aromatase inhibitors is associated with bone health: a cross-sectional observational study 2020 ·Breast Cancer Research and Treatment ·Takashi Saito, Rei Ono, Seishi Kono, (unknown), (unknown), Yuko Tanaka, Shintaro Takao, Yoshitada Sakai	5
5	Adipose-derived stem cells enhance human breast cancer growth and cancer stem cell-like properties through adipsin 2018 ·Oncogene ·Hideaki Goto, Yohei Shimono, Yohei Funakoshi, Yoshinori Imamura, Masanori Toyoda, Naomi Kiyota, Seishi Kono, Shintaro Takao, Toru Mukohara, Hironobu Minami	97
6	Effectiveness of Pertuzumab, Trastuzumab, and Docetaxel Combination Neoadjuvant Chemotherapy for HER2-Positive Inflammatory Breast Cancer: A Case Report 2017 ·Breast Care ·Yuji Yamashita, Yuko Tanaka, Seishi Kono, (unknown), Toru Mukohara, Yukiko Morinaga, Shigeo Hara, Shintaro Takao	4
7	Differences in elongation of very long chain fatty acids and fatty acid metabolism between triple-negative and hormone receptor-positive breast cancer 2017 ·BMC Cancer ·Yuji Yamashita, Shin Nishiumi, Seishi Kono, Shintaro Takao, Takeshi Azuma, Masaru Yoshida	58
8	Expression of programmed death‐1 in sentinel lymph nodes of breast cancer 2017 ·Journal of Surgical Oncology ·(unknown), Toru Mukohara, Yohei Shimono, Takashi Yamasaki, Yoshinori Imamura, Yohei Funakoshi, Masanori Toyoda, Naomi Kiyota, Shintaro Takao, Seishi Kono, Yoshihiro Kakeji, Hironobu Minami	3
9	Comparison of 2D- and 3D-culture models as drug-testing platforms in breast cancer breakdown → 2015 ·Oncology Reports ·Yoshinori Imamura, Toru Mukohara, Yohei Shimono, Yohei Funakoshi, Naoko Chayahara, Masanori Toyoda, Naomi Kiyota, Shintaro Takao, Seishi Kono, Tetsuya Nakatsura, Hironobu Minami	639
10	Abstract 319: Comparison of 2D- and 3D-culture models as drug-testing platforms in breast cancer 2015 ·Cancer Research ·Yoshinori Imamura, Toru Mukohara, Yohei Shimono, Yohei Funakoshi, Naoko Chayahara, Masanori Toyoda, Naomi Kiyota, Shintaro Takao, Seishi Kono, Tetsuya Nakatsura, Hironobu Minami	5
11	Absence of primary cilia in cell cycle‐arrested human breast cancer cells 2013 ·Genes to Cells ·Kentaro Nobutani, Yohei Shimono, Midori Yoshida, Kiyohito Mizutani, Akihiro Minami, Seishi Kono, Toru Mukohara, Takashi Yamasaki, Tomoo Itoh, Shintaro Takao, Hironobu Minami, Takeshi Azuma, Yoshimi Takai	42
12	Predictive factors for anthracycline-based chemotherapy for human breast cancer 2009 ·Breast Cancer ·Yasuo Miyoshi, Masafumi Kurosumi, Junichi Kurebayashi, Nariaki Matsuura∥, Masato Takahashi, Eriko Tokunaga, Chiyomi Egawa, Norikazu Masuda, Seishi Kono, Koji Morimoto, Seung Jin Kim, (unknown), Tetsu Yanagisawa, Satsuki Ueda, Tetsuya Taguchi, Yasuhiro Tamaki, Shinzaburo Noguchi	13
13	Nipple adenoma found in a mastectomy specimen: Report of a case with special regard to the proliferation pattern 2007 ·Breast Cancer ·Seishi Kono, Masafumi Kurosumi, (unknown), Kaori Kawanowa, Hiroyuki Takei, Kimito Suemasu	8
14	Immunohistochemical study of the relationship between Ki‐67 labeling index of proliferating cells of gynecomastia, histological phase and duration of disease 2006 ·Pathology International ·Seishi Kono, Masafumi Kurosumi, (unknown), Kaori Kawanowa, Jun Ninomiya, Hiroyuki Takei, Kimito Suemasu, Yoshikazu Kuroda	5
15	Histochemical, immunohistochemical, and ultrastructural studies of gingival fibromatosis: a case report 2002 ·PubMed ·(unknown), (unknown), Yoshiaki Kamikawa, Seishi Kono, (unknown), Kazumasa SUGIHARA, Shinichiro Tsuyama, Fusayoshi Murata	28

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact